Touchstone Innovations
19
14M
17
0.90
13
0.11
4
- Areas of investment
Summary
Touchstone Innovations appeared to be the Corporate Investor, which was created in 2001. The venture was found in Europe in United Kingdom. The main department of described Corporate Investor is located in the London.
The important activity for fund was in 2017. The fund is generally included in 2-6 deals every year. Opposing the other organizations, this Touchstone Innovations works on 18 percentage points less the average amount of lead investments. The real fund results show that this Corporate Investor is 52 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2019.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. The fund has exact preference in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Cell Medica, WaveOptics, Pulmocide. Among the most successful fund investment fields, there are Transportation, Commercial.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Touchstone Innovations, startups are often financed by Nesta Ventures, Pitch@Palace, Cambridge Angels group. The meaningful sponsors for the fund in investment in the same round are Mercia Technologies, Draper Esprit, Worldpay. In the next rounds fund is usually obtained by IP Group Plc, Robert Bosch Venture Capital, Octopus Ventures.
Investments analytics
Analytics
- Total investments
- 19
- Lead investments
- 13
- Exits
- 4
- Rounds per year
- 0.90
- Follow on index
- 0.11
- Investments by industry
- Health Care (6)
- Medical (5)
- Artificial Intelligence (4)
- FinTech (4)
- Machine Learning (4) Show 59 more
- Investments by region
-
- United Kingdom (19)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 40M
- Group Appearance index
- 0.84
- Avg. company exit year
- 13
- Avg. multiplicator
- 3.01
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| ApcinteX | 02 Feb 2017 | Health Care, Medical, Therapeutics | Early Stage Venture | 19M | England, London, United Kingdom |
| Pulmocide | 20 Mar 2017 | Biotechnology, Drug Discovery, Pharmaceuticals, Health Care, Health Diagnostics, Medical Device, Medical | Early Stage Venture | 30M | England, London, United Kingdom |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.